ホルモン避妊薬の世界市場:手法別(ピル、子宮内避妊器具(IUD)、パッチ、インプラント、避妊リング、注射剤)、地域別、供給業者勢力図、セグメント予測

Grand View Researchが発行した調査報告書(GVIEW805060)
◆英語タイトル:Hormonal Contraceptive Market Size, Share & Trends Analysis Report By Method (Pill, Intrauterine Device (IUD), Patch, Implant, Vaginal Ring, Injectable), By Region, Vendor Landscape, And Segment Forecasts, 2018 - 2025
◆商品コード:GVIEW805060
◆発行会社(リサーチ会社):Grand View Research
◆発行日:2018年3月19日
◆ページ数:100
◆レポート形式:英語 / PDF
◆納品方法:Eメール
◆調査対象地域:グローバル
◆産業分野:Healthcare
◆販売価格オプション(消費税別)
Single UserUSD5,950 ⇒換算¥684,250見積依頼/購入/質問フォーム
Multi UserUSD7,950 ⇒換算¥914,250見積依頼/購入/質問フォーム
Global/corporate LicenseUSD9,950 ⇒換算¥1,144,250見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGrand View Research社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。Grand View Research社の概要及び新刊レポートはこちらでご確認いただけます。

本調査レポートでは、ホルモン避妊薬の世界市場について調査・分析し、ホルモン避妊薬の世界市場動向、ホルモン避妊薬の世界市場規模、市場予測、セグメント別ホルモン避妊薬市場分析、主要地域別市場規模、競争状況、関連企業情報などを含め、以下の構成でお届け致します。
【レポートの概要】

The global hormonal contraceptive market size is expected to reach USD 26.2 billion by 2025, according to a new report by Grand View Research, Inc., registering a CAGR of 4.0% during the forecast period. Introduction of innovative products in the market and growing awareness about reproductive and sexual health in emerging regions are likely to drive the market in the coming years.
Pill, Intrauterine Devices (IUD), injectable, vaginal rings, implants, and patches are various methods used for hormonal contraception. Hormonal contraception methods act on the endocrine system to prevent ovulation.

Increasing number of women in developing economies are using contraceptives due to rise in government initiatives and programs, which is anticipated to accelerate market growth. For instance, according to the UN, approximately 64.0% of women between 15 and 49 years of age were using some form of family planning in 2015, be it traditional or modern. This figure stood at 36.0% in 1970.

The number of unintended pregnancies annually is highest in U.S., which is about 3 million. Hence, the Center for Medicaid and CHIP Services (CMCS) established a Maternal and Infant Health Initiative for the Medicaid and Children’s Health Insurance Program (CHIP) program to promote use of effective methods of contraception and help women avoid such pregnancies.

Further key findings from the report suggest:

• Increasing demand for contraceptive methods can be attributed to growing awareness about pills and devices, increasing significance of family planning, and supportive government regulations improving access to these products

• In 2016, pills accounted for the largest share in the market as they are convenient to use and exhibit more than 99.0% effectivity when accurately consumed. Furthermore, ease of availability, fewer adverse effects, and large number of players operating in the market can be attributed to this share

• The IUD segment is expected to witness the fastest growth during the forecast period. This can be attributed to entry of new devices in the market over the recent past, availability of long-acting reversible birth control methods, and more than 99.0% effectivity

• Geographically, North America held the largest share in 2016 and is anticipated to maintain its dominance during the forecast period due to local presence of market players, high per capita income, and supportive government initiatives

• Asia Pacific is estimated to witness the fastest growth during the forecast period due to high unmet need, expected increase in coverage during the next 15 years, and increasing number of women of reproductive age

• Some of the key players operating in the market are Teva Pharmaceuticals Industries Ltd.; Bayer AG, Merck & Co. Inc.; Pfizer, Afaxys, Inc.; Agile Therapeutics; Allergan; and Apothecus Pharmaceutical Corporation.

【レポートの目次】

Table of Contents

Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
1.3. List of Data Sources
Chapter 2. Executive Summary
2.1. Market Snapshot
Chapter 3. Hormonal Contraceptive Industry Outlook
3.1. Market Segmentation
3.2. Market Size and Growth Prospects, 2014 – 2025
3.3. Market Dynamics
3.3.1. Market driver analysis
3.3.2. Market restraint analysis
3.4. Key Opportunities Prioritized
3.5. Industry Analysis – Porter’s
3.6. PESTEL Analysis, 2016
3.7. Hormonal Contraceptive Competitive Scenario, 2016
3.7.1. Competitive landscape/Heat map analysis: Market position analysis (based on product portfolio, regional presence, and strategic initiatives)
Chapter 4. Hormonal Contraceptive Market: Method Outlook
4.1. Hormonal Contraceptive Market Share by Method, 2016 & 2025 (USD Million)
4.2. Pill
4.2.1. Market estimates and forecast, 2014 – 2025 (USD Million)
4.3. Intrauterine Devices (IUD)
4.3.1. Market estimates and forecast, 2014 – 2025 (USD Million)
4.4. Injectable
4.4.1. Market estimates and forecast, 2014 – 2025 (USD Million)
4.5. Vaginal Ring
4.5.1. Market estimates and forecast, 2014 – 2025 (USD Million)
4.6. Implant
4.6.1. Market estimates and forecast, 2014 – 2025 (USD Million)
4.7. Patch
4.7.1. Market estimates and forecast, 2014 – 2025 (USD Million)
Chapter 5. Hormonal Contraceptive Market: Regional Outlook
5.1. Growth Hormone Market Share by Region, 2016 & 2025 (USD Million)
5.2. North America
5.2.1. Market estimates and forecast, by country, 2014 – 2025 (USD Million)
5.2.2. Market estimates and forecast, by method, 2014 – 2025 (USD Million)
5.2.3. U.S.
5.2.3.1. Market estimates and forecast, by method, 2014 – 2025 (USD Million)
5.2.4. Canada
5.2.4.1. Market estimates and forecast, by method, 2014 – 2025 (USD Million)
5.3. Europe
5.3.1. Market estimates and forecast, by country, 2014 – 2025 (USD Million)
5.3.2. Market estimates and forecast, by method, 2014 – 2025 (USD Million)
5.3.3. Germany
5.3.3.1. Market estimates and forecast, by method, 2014 – 2025 (USD Million)
5.3.4. U.K.
5.3.4.1. Market estimates and forecast, by method, 2014 – 2025 (USD Million)
5.4. Asia Pacific
5.4.1. Market estimates and forecast, by country, 2014 – 2025 (USD Million)
5.4.2. Market estimates and forecast, by method, 2014 – 2025 (USD Million)
5.4.3. China
5.4.3.1. Market estimates and forecast, by method, 2014 – 2025 (USD Million)
5.4.4. Japan
5.4.4.1. Market estimates and forecast, by method, 2014 – 2025 (USD Million)
5.5. Latin America
5.5.1. Market estimates and forecast, by country, 2014 – 2025 (USD Million)
5.5.2. Market estimates and forecast, by method, 2014 – 2025 (USD Million)
5.5.3. Brazil
5.5.3.1. Market estimates and forecast, by method, 2014 – 2025 (USD Million)
5.5.4. Mexico
5.5.4.1. Market estimates and forecast, by method, 2014 – 2025 (USD Million)
5.6. Middle East & Africa
5.6.1. Market estimates and forecast, by country, 2014 – 2025 (USD Million)
5.6.2. Market estimates and forecast, by method, 2014 – 2025 (USD Million)
5.6.3. South Africa
5.6.3.1. Market estimates and forecast, by method, 2014 – 2025 (USD Million)
Chapter 6. Competitive Landscape
6.1. Strategy Framework
6.2. Company Profiles
6.2.1. Allergan
6.2.1.1. Company overview
6.2.1.2. Financial performance
6.2.1.3. Product portfolio
6.2.1.4. Strategic initiatives
6.2.2. Bayer AG
6.2.2.1. Company overview
6.2.2.2. Financial performance
6.2.2.3. Product portfolio
6.2.2.4. Strategic initiatives
6.2.3. Merck & Co., Inc.
6.2.3.1. Company overview
6.2.3.2. Financial performance
6.2.3.3. Product portfolio
6.2.3.4. Strategic initiatives
6.2.4. Pfizer
6.2.4.1. Company overview
6.2.4.2. Financial performance
6.2.4.3. Product portfolio
6.2.4.4. Strategic initiatives
6.2.5. Afaxys, Inc.
6.2.5.1. Company overview
6.2.5.2. Financial performance
6.2.5.3. Product portfolio
6.2.5.4. Strategic initiatives
6.2.6. Teva Pharmaceutical Industries Ltd
6.2.6.1. Company overview
6.2.6.2. Financial performance
6.2.6.3. Product portfolio
6.2.6.4. Strategic initiatives
6.2.7. Agile Therapeutics
6.2.7.1. Company overview
6.2.7.2. Financial performance
6.2.7.3. Product portfolio
6.2.7.4. Strategic initiatives
6.2.8. Apothecus Pharmaceutical Corp.
6.2.8.1. Company overview
6.2.8.2. Financial performance
6.2.8.3. Product portfolio
6.2.8.4. Strategic initiatives


List of Tables

TABLE 1 North America hormonal contraceptive market estimates and forecast by country, 2014 - 2025 (USD Million)
TABLE 2 North America hormonal contraceptive market estimates and forecast by method, 2014 - 2025 (USD Million)
TABLE 3 U.S. hormonal contraceptive market estimates and forecast by method, 2014 - 2025 (USD Million)
TABLE 4 Canada hormonal contraceptive market estimates and forecast by method, 2014 - 2025 (USD Million)
TABLE 5 Europe hormonal contraceptive market estimates and forecast by country, 2014 - 2025 (USD Million)
TABLE 6 Europe hormonal contraceptive market estimates and forecast by method, 2014 - 2025 (USD Million)
TABLE 7 Germany hormonal contraceptive market estimates and forecast by method, 2014 - 2025 (USD Million)
TABLE 8 U.K. hormonal contraceptive market estimates and forecast by method, 2014 - 2025 (USD Million)
TABLE 9 Asia Pacific hormonal contraceptive market estimates and forecast by country, 2014 - 2025 (USD Million)
TABLE 10 Asia Pacific hormonal contraceptive market estimates and forecast by method, 2014 - 2025 (USD Million)
TABLE 11 Japan hormonal contraceptive market estimates and forecast by method, (USD Million)
TABLE 12 China hormonal contraceptive market estimates and forecast by method, 2014 - 2025 (USD Million)
TABLE 13 Latin America hormonal contraceptive market estimates and forecast by country, 2014 - 2025 (USD Million)
TABLE 14 Latin America hormonal contraceptive market estimates and forecast by method, 2014 - 2025 (USD Million)
TABLE 15 Brazil hormonal contraceptive market estimates and forecast by method, 2014 - 2025 (USD Million)
TABLE 16 Mexico hormonal contraceptive market estimates and forecast by method, 2014 - 2025 (USD Million)
TABLE 17 Middle East & Africa hormonal contraceptive market estimates and forecast by country, 2014 - 2025 (USD Million)
TABLE 18 Middle East & Africa hormonal contraceptive market estimates and forecast by method, 2014 - 2025 (USD Million)
TABLE 19 South Africa hormonal contraceptive market estimates and forecast by method, 2014 - 2025 (USD Million)

List of Figures

FIG. 1 Market research process
FIG. 2 Information procurement
FIG. 3 Primary research pattern
FIG. 4 Market research approaches
FIG. 5 Value chain based sizing & forecasting
FIG. 6 QFD modeling for market share assessment
FIG. 7 contraceptive market summary 2016, (USD Million)
FIG. 8 Market trends & outlook
FIG. 9 Market segmentation & scope
FIG. 10 Market driver relevance analysis (Current & future impact)
FIG. 11 Market restraint relevance analysis (Current & future impact)
FIG. 12 Penetration & growth prospect mapping
FIG. 13 SWOT analysis, by factor (political & legal, economic, and technological)
FIG. 14 Porter’s Five Forces Analysis
FIG. 15 Hormonal contraceptive competitive landscape: Market position analysis (based on products, regional presence, and strategic initiatives)
FIG. 16 Hormonal contraceptive market, method outlook key takeaways
FIG. 17 Hormonal contraceptive: Method movement analysis
FIG. 18 Pill market, 2014 - 2025 (USD Million)
FIG. 19 Intrauterine devices market, 2014 - 2025 (USD Million)
FIG. 20 Injectable market, 2014 - 2025 (USD Million)
FIG. 21 Vaginal ring market, 2014 - 2025 (USD Million)
FIG. 21 Implant market, 2014 - 2025 (USD Million)
FIG. 21 Patch market, 2014 - 2025 (USD Million)
FIG. 22 Regional market place: Key takeaways
FIG. 23 Hormonal contraceptive market: Regional movement analysis
FIG. 24 North America hormonal contraceptive market, 2014 - 2025 (USD Million)
FIG. 25 U.S. hormonal contraceptive market, 2014 - 2025 (USD Million)
FIG. 26 Canada hormonal contraceptive market, 2014 - 2025 (USD Million)
FIG. 27 Europe hormonal contraceptive market, 2014 - 2025 (USD Million)
FIG. 28 U.K. hormonal contraceptive market, 2014 - 2025 (USD Million)
FIG. 29 Germany hormonal contraceptive market, 2014 - 2025 (USD Million)
FIG. 30 Asia Pacific hormonal contraceptive market, 2014 - 2025 (USD Million)
FIG. 31 Japan hormonal contraceptive market, 2014 - 2025 (USD Million)
FIG. 32 China hormonal contraceptive market, 2014 - 2025 (USD Million)
FIG. 33 Latin America hormonal contraceptive market, 2014 - 2025 (USD Million)
FIG. 34 Brazil hormonal contraceptive market, 2014 - 2025 (USD Million)
FIG. 35 Mexico hormonal contraceptive market, 2014 - 2025 (USD Million)
FIG. 36 MEA hormonal contraceptive market, 2014 - 2025 (USD Million)
FIG. 37 South Africa hormonal contraceptive market, 2014 - 2025 (USD Million)
FIG. 38 Competitive strategy adopted by leading players

【免責事項】
https://www.globalresearch.jp/disclaimer

★リサーチレポート[ ホルモン避妊薬の世界市場:手法別(ピル、子宮内避妊器具(IUD)、パッチ、インプラント、避妊リング、注射剤)、地域別、供給業者勢力図、セグメント予測(Hormonal Contraceptive Market Size, Share & Trends Analysis Report By Method (Pill, Intrauterine Device (IUD), Patch, Implant, Vaginal Ring, Injectable), By Region, Vendor Landscape, And Segment Forecasts, 2018 - 2025)]についてメールでお問い合わせはこちらでお願いします。